4DMedical Limited (FDMDF)
4DMedical Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Carlton, VIC, AU. The stock last traded at $2.75, up 0.00% on the session, giving a market capitalisation of $1.65B. On trailing twelve-month figures it carries a trailing P/E of -10.15, a net margin of -2895.1%. Its beta of 1.97 implies it has historically moved more than the broad market.
4DMedical Limited operates as a medical technology firm with operations spanning both Australia and the United States. A core aspect of its business involves the commercialization of XV Technology, an advanced four-dimensional system for lung imaging. The company's offerings further extend to a software-as-a-service (SaaS) delivery model, alongside its proprietary XV lung ventilation analysis software. Additional products include Permetium, a preclinical imaging system designed to quantify localized changes in pulmonary function, and the AccuVent 200, a ventilator specifically tailored for small animals. Established in 2012, 4DMedical Limited is headquartered in Carlton, Australia.
4DMedical Limited is most often compared with the following Healthcare names: